Home Andromeda Biotech

Andromeda Biotech

acquired
-
Developer of Autoimmune Diabetes Treatment
Basic
Enterprise Profile

Basic Information

The company provides DiaPep277, a product for treating Type 1 Diabetes (T1D). The company's product is a peptide that represents a treatment method to prevent the destruction of insulin-producing cells in the pancreas.
Andromeda Biotech Ltd.
Israel
unclear
January 01, 2007
--

Enterprise Profile

Concept
Immune System Diseases # Diabetes Mellitus